# Baldwin Insurance Group, Inc.: Form 10-Q for the period ended Sep 30, 2022

- Company: [Baldwin Insurance Group, Inc.](/companies/bwin.md) (CIK 1781755)
- Form: 10-Q
- Filed: 2022-11-07
- Accepted by EDGAR: Nov 7, 2022, 16:27 ET
- Period: 2022-09-30
- Accession: 0001781755-22-000033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781755/000178175522000033/brp-20220930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781755/000178175522000033/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 3 months, 2022-07-01 to 2022-09-30 | −$29.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | $35.3m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | −$24.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | $6.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-07-01 to 2022-09-30 | −$0.43 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | −$0.43 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | $0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-01 to 2022-09-30 | 57,282,132 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 59,895,371 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | −$16.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $15.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-09-30 | $158.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-09-30 | $710.9m | us-gaap:AssetsCurrent |
| Total assets | at 2022-09-30 | $3.41bn | us-gaap:Assets |
| Current liabilities | at 2022-09-30 | $573.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-09-30 | $2.19bn | us-gaap:Liabilities |
| Current portion of debt | at 2022-09-30 | $8.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-09-30 | $651.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 70,527 characters.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 1, 2022. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part II, Item 1A. Risk Factors and Note Regarding Forward-Looking Statements included elsewhere in this Quarterly Report on Form 10-Q and under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.

### THE COMPANY

BRP Group, Inc. (“BRP Group,” the “Company,” “we,” “us” or “our”) is an independent insurance distribution firm delivering tailored insurance and risk management insights and solutions that give our Clients the peace of mind to pursue their purpose, passion and dreams. We support our Clients, Colleagues, Insurance Company Partners and communities through the deployment of vanguard resources, technology and capital to drive organic and inorganic growth. When we consistently execute for these key stakeholders, we believe that the outcome is an increase in value for our fifth stakeholder, our shareholders. We are innovating the industry by taking a holistic and tailored approach to risk management, insurance and employee benefits. Our growth plan includes continuing to recruit, train and develop industry leading talent, continuing to add geographic representation, insurance product expertise and end-client industry expertise via our Partnership strategy, and the continued buildout of our MGA of the Future platform, which delivers proprietary, technology-enabled insurance solutions to our internal Risk Advisors as well as to a growing channel of external distribution partners. We are a destination employer supported by an award-winning culture, powered by exceptional people and fueled by industry-leading growth and innovation.

We represent over 1,200,000 Clients across the United States and internationally. Our more than 3,800 Colleagues include over 640 Risk Advisors, who are fiercely independent, relentlessly competitive and “insurance geeks.” We have approximately 125 offices in 23 states, all of which are equipped to provide diversified products and services to empower our Clients at every stage through our four Operating Groups.

- **Middle Market** provides expertly-designed commercial risk management, employee benefits solutions and private risk management for mid-to-large-size businesses and high net worth individuals, as well as their families.
- **MainStreet** offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities.
- **Medicare** offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents. In the Medicare Operating Group, we generate commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with our Insurance Company Partners.
- **Specialty** consists of two distinct businesses with MGA of the Future representing approximately 86% of the revenue. Our specialty wholesale broker businesses deliver specialty insurers, professionals, individuals and niche industry businesses expanded access to exclusive specialty markets, capabilities and programs requiring complex underwriting and placement. Specialty also houses our MGA of the Future platform, in which we deliver proprietary, technology enabled insurance products that are then distributed (in many instances via technology and/or API integrations) internally via our Risk Advisors in Middle Market and MainStreet and externally via select distribution partners, with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, an example of which is our national embedded renter’s insurance product sold at point of lease via integrations with property management software providers.

In 2011, we adopted the “Azimuth” as our corporate constitution. Named after a historical navigation tool used to find “true north,” the Azimuth asserts our core values, business basics and stakeholder promises. The ideals encompassed by the Azimuth support our mission to deliver indispensable, tailored insurance and risk management insights and solutions to our Clients. We strive to be regarded as the preeminent insurance advisory firm fueled by relationships, powered by people and exemplified by Client adoption and loyalty. This type of environment is upheld by the distinct vernacular we use to describe our services and culture. We are a firm, instead of an agency; we have Colleagues, instead of employees; we have Risk Advisors, instead of producers/agents. We serve Clients instead of customers and we refer to our acquisitions as Partnerships. We refer to insurance brokerages that we have acquired, or in the case of asset acquisitions, the producers, as Partners.

### Seasonality

The insurance brokerage market is seasonal and our results of operations are somewhat affected by seasonal trends. Our Adjusted EBITDA and Adjusted EBITDA Margins are typically highest in the first quarter and lowest in the fourth quarter. This variation is primarily due to fluctuations in our revenues, while overhead remains consistent throughout the year. Our revenues are generally highest in the first quarter due to the impact of contingent payments received in the first quarter from Insurance Company Partners that we cannot readily estimate before receipt without the risk of significant reversal and a higher degree of first quarter policy commencements and renewals in Medicare and certain Middle Market lines of business such as employee benefits and commercial. In addition, a higher proportion of our first quarter revenue is derived from our highest margin businesses.

Partnerships can significantly impact Adjusted EBITDA and Adjusted EBITDA Margins in a given year and may increase the amount of seasonality within the business, especially results attributable to Partnerships that have not been fully integrated into our business or owned by us for a full year.

### PARTNERSHIPS

We utilize strategic acquisitions, which we refer to as Partnerships, to complement and expand our business. We source Partnerships through proprietary deal flow, competitive auctions and cultivated industry relationships. We are currently considering Partnership opportunities in all of our Operating Groups, including businesses to complement or expand our MGA of the Future.

The financial impact of Partnerships may affect the comparability of our results from period to period. Our acquisition strategy also entails certain risks, including the risks that we may not be able to successfully source, value, close, integrate and effectively manage businesses that we acquire. To mitigate that risk, we have a professional team focused on finding new Partners and integrating new Partnerships. Executing on Partnership opportunities is a key pillar in our long-term growth strategy over the next seven years.

We completed three Partnerships for an aggregate purchase price of $415.4 million during the nine months ended September 30, 2022 and ten Partnerships for an aggregate purchase price of $387.5 million during the nine months ended September 30, 2021. Partnerships completed during 2022 added a total of $4.4 million of premiums, commissions and fees receivable, $224.3 million of intangible assets and $188.7 million of goodwill to the condensed consolidated balance sheet on the Partnership date.

### RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements for the three and nine months ended September 30, 2022 and the related notes and other financial information included elsewhere in this report. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.

The following is a discussion of our consolidated results of operations for the three and nine months ended September 30, 2022 and 2021.

*(in thousands)*

| Revenues: | For the Three Months Ended September 30, 2022 | 2021 | Variance | For the Nine Months Ended September 30, 2022 | 2021 | Variance |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Commissions and fees | $259,368 | $135,556 | $123,812 | $734,676 | $408,090 | $326,586 |
| Operating expenses: |  |  |  |  |  |  |
| Commissions, employee compensation and benefits | 195,920 | 100,081 | 95,839 | 522,518 | 278,521 | 243,997 |
| Other operating expenses | 47,212 | 27,968 | 19,244 | 124,424 | 64,380 | 60,044 |
| Amortization expense | 23,180 | 12,596 | 10,584 | 59,912 | 33,875 | 26,037 |
| Change in fair value of contingent consideration | 21,695 | 11,341 | 10,354 | (10,809) | 23,163 | (33,972) |
| Depreciation expense | 1,216 | 753 | 463 | 3,309 | 1,920 | 1,389 |
| Total operating expenses | 289,223 | 152,739 | 136,484 | 699,354 | 401,859 | 297,495 |
| Operating income (loss) | (29,855) | (17,183) | (12,672) | 35,322 | 6,231 | 29,091 |
| Other income (expense): |  |  |  |  |  |  |
| Interest expense, net | (20,766) | (6,940) | (13,826) | (45,748) | (18,431) | (27,317) |
| Other income (expense), net | 3,914 | (478) | 4,392 | 25,151 | (1,535) | 26,686 |
| Total other expense | (16,852) | (7,418) | (9,434) | (20,597) | (19,966) | (631) |
| Net income (loss) | (46,707) | (24,601) | (22,106) | 14,725 | (13,735) | 28,460 |
| Less: net income (loss) attributable to noncontrolling interests | (21,914) | (11,389) | (10,525) | 8,007 | (5,736) | 13,743 |
| Net income (loss) attributable to BRP Group, Inc. | $(24,793) | $(13,212) | $(11,581) | $6,718 | $(7,999) | $14,717 |

### Commissions and Fees

We earn commissions and fees by facilitating the arrangement between Insurance Company Partners and individuals or businesses for the carrier to provide insurance to the insured party. Our commissions and fees are usually a percentage of the premium paid by the insured and generally depends on the type of insurance, the particular Insurance Company Partner and the nature of the services provided. Under certain arrangements with Clients, we earn pre-negotiated service fees in lieu of commissions. Additionally, we may also receive from Insurance Company Partners a profit-sharing commission, or straight override, which represent forms of variable consideration associated with the placement of coverage and are based primarily on underwriting results, but may also contain considerations for volume, growth or retention.

Commissions and fees increased $123.8 million and $326.6 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively. The increase for the periods related to amounts attributable to Partners acquired during 2021 and 2022 prior to their having reached the twelve-month owned mark (such amounts, the “Partnership Contribution”) and organic growth. The Partnership Contribution accounted for $85.8 million and $234.8 million of the increase to commissions and fees for the quarter and year-to-date periods, respectively, and organic growth accounted for $38.0 million and $91.8 million of the increase for the quarter and year-to-date periods, respectively.

### Major Sources of Commissions and Fees

The following table sets forth our commissions and fees by major source for the periods indicated:

*(in thousands)*

|  | For the Three Months Ended September 30, 2022 | 2021 | Variance | For the Nine Months Ended September 30, 2022 | 2021 | Variance |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Direct bill revenue | $111,369 | $58,582 | $52,787 | $336,563 | $203,302 | $133,261 |
| Agency bill revenue | 92,895 | 53,495 | 39,400 | 255,087 | 136,271 | 118,816 |
| Profit-sharing revenue | 15,044 | 8,105 | 6,939 | 49,422 | 26,572 | 22,850 |
| Consulting and service fee revenue | 17,572 | 7,893 | 9,679 | 44,097 | 22,470 | 21,627 |
| Policy fee and installment fee revenue | 18,036 | 5,146 | 12,890 | 37,163 | 14,414 | 22,749 |
| Other income | 4,452 | 2,335 | 2,117 | 12,344 | 5,061 | 7,283 |
| Total commissions and fees | $259,368 | $135,556 | $123,812 | $734,676 | $408,090 | $326,586 |

Direct bill revenue represents commission revenue earned by providing insurance placement services to Clients, primarily for private risk management, commercial risk management, employee benefits and Medicare insurance types. Direct bill revenue increased by $52.8 million and $133.3 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively. The Partnership Contribution accounted for $42.9 million and $105.2 million of the increase to direct bill revenue for the quarter and year-to-date periods, respectively. Organic growth for direct bill revenue was $9.9 million and $28.1 million for the quarter and year-to-date periods, respectively.

Agency bill revenue primarily represents commission revenue earned by providing insurance placement services to clients wherein we act as an agent on behalf of the Client. Agency bill revenue increased $39.4 million and $118.8 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively. The Partnership Contribution accounted for $29.7 million and $91.7 million of the increase to agency bill revenue for the quarter and year-to-date periods, respectively. Organic growth for agency bill revenue was $9.7 million and $27.1 million for the quarter and year-to-date periods, respectively.

Profit-sharing revenue represents bonus-type or contingent revenue that is earned by us as a sales incentive provided by certain Insurance Company Partners. Profit-sharing revenue increased $6.9 million and $22.9 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively, as a result of the Partnership Contribution of $3.8 million and $13.3 million, respectively, and organic growth of $3.1 million and $9.6 million, respectively. Profit-sharing revenue can be affected by higher loss ratios in our Middle Market and MainStreet Operating Groups, which is particularly acute in the Florida homeowners marketplace.

Consulting and service fee revenue represents fees received in lieu of a commission and specialty insurance consulting revenue. Consulting and service fee revenue increased $9.7 million and $21.6 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively, as a result of the Partnership Contribution of $8.2 million and $17.8 million, respectively, and organic growth of $1.5 million and $3.8 million, respectively.

Policy fee and installment fee revenue represents revenue earned for acting in the capacity of an MGA and providing payment processing and services and other administrative functions on behalf of Insurance Company Partners. Policy fee and installment fee revenue increased $12.9 million and $22.7 million during the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively, primarily due to organic growth. These fees are generated by our Specialty Operating Group.

Other income consists of Medicare marketing income that is based on agreed-upon cost reimbursement for fulfilling specific targeted marketing campaigns in addition to other ancillary income and premium financing income generated across all Operating Groups. Other income increased $2.1 million and $7.3 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively. The increase in other income for the year-to-date period is primarily attributable to the Partnership Contribution for our Specialty and Middle Market Operating Groups.

### Commissions, Employee Compensation and Benefits

Commissions, employee compensation and benefits is our largest expense. It consists of (a) base compensation comprising salary, bonuses and benefits paid and payable to Colleagues, commissions paid to Colleagues and outside commissions paid to others; and (b) equity-based compensation associated with the grants of restricted and unrestricted stock awards to senior management, Colleagues, Risk Advisors and directors. We expect to continue to experience a general rise in commissions, employee compensation and benefits expense commensurate with expected growth in our revenue and headcount. We operate in competitive markets for human capital and need to maintain competitive compensation levels as we expand geographically and create new products and services. Our Colleague-related costs have risen as a result of the increasingly competitive market and the inflationary environment.

Our compensation arrangements with our employees contain significant bonus or commission components driven by the results of our operations. Therefore, as we grow commissions and fees, we expect compensation costs to rise.

Commissions, employee compensation and benefits expenses increased $95.8 million and $244.0 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively. The Partnership Contribution accounted for $44.4 million and $126.7 million of the increase to commissions, employee compensation and benefits for the quarter and year-to-date periods, respectively. Share-based compensation expense increased $4.6 million and $14.1 million, respectively, as a result of equity grants awarded to all newly hired Colleagues, including those who joined us through Partnerships, and grants to reward Colleagues, including members of senior management. The remaining increase in commissions, employee compensation and benefits expense can be attributed to higher commissions expense relating to our organic growth, higher compensation and benefits related to hiring to support our growth, and the inflationary environment, which has resulted in significant increases in the cost of human capital.

### Other Operating Expenses

Other operating expenses include travel, accounting, legal and other professional fees, placement fees, rent, office expenses and other costs associated with our operations. Our occupancy-related costs and professional services expenses, in particular, generally increase or decrease in relative proportion to the number of our employees and the overall size and scale of our business operations.

Other operating expenses increased $19.2 million for the three months ended September 30, 2022 as compared to the same period of 2021, which was primarily attributable to increases in dues and subscriptions of $5.1 million from our investment in technology to support our growth, travel and entertainment of $4.7 million relating to integration of our 2021 Partnerships and our leadership and Risk Advisor conference, advertising and marketing of $2.8 million, rent expense of $1.4 million relating to expansion of our operating locations, Colleague education and welfare of $1.2 million relating to investments in our Colleagues, and repairs and maintenance of $1.1 million.

Other operating expenses increased $60.0 million for the nine months ended September 30, 2022 as compared to the same period of 2021, which was primarily attributable to increases in dues and subscriptions of $12.0 million from our investment in technology to support our growth, travel and entertainment of $9.2 million relating to integration of our 2021 Partnerships and our leadership and Risk Advisor conference, rent expense of $7.2 million relating to expansion of our operating locations, Colleague education and welfare of $5.6 million relating to investments in our Colleagues, advertising and marketing of $5.4 million, professional fees of $3.8 million, licenses and taxes of $3.5 million relating to revenue growth, repairs and maintenance of $3.4 million, and recruiting expense of $2.4 million.

### Amortization Expense

Amortization expense increased $10.6 million and $26.0 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively, which was driven by amortization of intangible assets recorded in connection with Partnerships over the past twelve months.

### Change in Fair Value of Contingent Consideration

Change in fair value of contingent consideration was a $21.7 million loss for the three months ended September 30, 2022 as compared to a $11.3 million loss for the same period of 2021. The change in fair value of contingent consideration for the third quarter of 2022 was impacted by changes in growth trends of certain partners, offset in part by high market volatility and rising interest rates, which resulted in an overall higher contingent earnout consideration value.

Change in fair value of contingent consideration was a $10.8 million gain for the nine months ended September 30, 2022 as compared to a $23.2 million loss for the same period of 2021. The change in fair value of contingent consideration for the year-to-date period of 2022 was impacted by high market volatility and rising interest rates, offset in part by changes in growth trends of certain partners, which resulted in an overall lower contingent earnout consideration value.

### Depreciation Expense

Depreciation expense increased $0.5 million and $1.4 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively, which was driven by our growth.

### Interest Expense, Net

Interest expense, net increased $13.8 million and $27.3 million for the three and nine months ended September 30, 2022 as compared to the same periods of 2021, respectively, resulting from higher average borrowings outstanding and higher average interest rates related to increases in the benchmark rates for our variable rate debt.

Refer to Item 3. Qualitative and Quantitative Disclosures About Market Risk for further discussion of the impact of rising interest rates on our results of operations, financial condition and cash flows.

### Other Income (Expense), Net

Other income (expense), net was $3.9 million and $25.2 million for the three and nine months ended September 30, 2022, primarily as a result of a gain on interest rate caps of $4.2 million and $25.4 million recorded during the quarter and year-to-date periods, respectively, in connection with rising interest rates and market estimates for future rate increases. The gain for the year-to-date period includes $13.5 million that was realized in connection with our sale of three interest rate caps during the second quarter.

### NON-GAAP FINANCIAL MEASURES

Adjusted EBITDA, Adjusted EBITDA Margin, Organic Revenue, Organic Revenue Growth, Adjusted Net Income and Adjusted Diluted Earnings Per Share (“EPS”), are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for Organic Revenue and Organic Revenue Growth), net income (loss) (for Adjusted EBITDA and Adjusted EBITDA Margin) net income (loss) attributable to BRP Group, Inc. (for Adjusted Net Income) or diluted earnings (loss) per share (for Adjusted Diluted EPS), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to BRP Group, Inc., diluted earnings (loss) per share or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly these measures may not be comparable to similarly titled measures used by other companies.

We define Adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related expenses related to Partnerships, severance, and certain non-recurring items, including those related to raising capital. We believe that Adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.

Adjusted EBITDA Margin is Adjusted EBITDA divided by commissions and fees. Adjusted EBITDA Margin is a key metric used by management and our board of directors to assess our financial performance. We believe that Adjusted EBITDA Margin is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that Adjusted EBITDA Margin is helpful in measuring profitability of operations on a consolidated level.

Adjusted EBITDA and Adjusted EBITDA Margin have important limitations as analytical tools. For example, Adjusted EBITDA and Adjusted EBITDA Margin:

- do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;
- do not reflect changes in, or cash requirements for, our working capital needs;
- do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;
- do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;
- do not reflect share-based compensation expense and other non-cash charges; and
- exclude certain tax payments that may represent a reduction in cash available to us.

We calculate Organic Revenue based on commissions and fees for the relevant period by excluding the first twelve months of commissions and fees generated from new Partners. Organic Revenue Growth is the change in Organic Revenue period-to-period, with prior period results adjusted to include commissions and fees that were excluded from Organic Revenue in the prior period because the relevant Partners had not yet reached the twelve-month owned mark, but which have reached the twelve-month owned mark in the current period. For example, revenues from a Partner acquired on June 1, 2021 are excluded from Organic Revenue for 2021. However, after June 1, 2022, results from June 1, 2021 to December 31, 2021 for such Partners are compared to results from June 1, 2022 to December 31, 2022 for purposes of calculating Organic Revenue Growth in 2022. Organic Revenue Growth is a key metric used by management and our board of directors to assess our financial performance. We believe that Organic Revenue and Organic Revenue Growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.

Adjusted Net Income is presented for the purpose of calculating Adjusted Diluted EPS. We define Adjusted Net Income as net income (loss) attributable to BRP Group, Inc. adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related expenses related to Partnerships, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance.

Adjusted Diluted EPS measures our per share earnings excluding certain expenses as discussed above and assuming all shares of Class B common stock were exchanged for Class A common stock. Adjusted Diluted EPS is calculated as Adjusted Net Income divided by adjusted dilutive weighted-average shares outstanding. We believe Adjusted Diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.

### Adjusted EBITDA and Adjusted EBITDA Margin

The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net income (loss), which we consider to be the most directly comparable GAAP financial measure:

*(in thousands, except percentages)*

|  | For the Three Months Ended September 30, 2022 | 2021 | For the Nine Months Ended September 30, 2022 | 2021 |
| --- | ---: | ---: | ---: | ---: |
| Commissions and fees | $259,368 | $135,556 | $734,676 | $408,090 |
| Net income (loss) | $(46,707) | $(24,601) | $14,725 | $(13,735) |
| Adjustments to net income (loss): |  |  |  |  |
| Amortization expense | 23,180 | 12,596 | 59,912 | 33,875 |
| Interest expense, net | 20,766 | 6,940 | 45,748 | 18,431 |
| Transaction-related Partnership and integration expenses | 12,128 | 5,556 | 29,552 | 11,226 |
| Share-based compensation | 8,388 | 3,834 | 26,065 | 11,921 |
| (Gain) loss on interest rate caps | (4,151) | 334 | (25,420) | 1,159 |
| Change in fair value of contingent consideration | 21,695 | 11,341 | (10,809) | 23,163 |
| Depreciation expense | 1,216 | 753 | 3,309 | 1,920 |
| Severance | 260 | 481 | 1,135 | 481 |
| Other(1) | 5,109 | 1,951 | 13,083 | 4,222 |
| Adjusted EBITDA | $41,884 | $19,185 | $157,300 | $92,663 |
| Adjusted EBITDA Margin | 16% | 14% | 21% | 23% |

(1) Other addbacks to Adjusted EBITDA include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, remediation efforts, professional fees and litigation costs, and bonuses.

### Organic Revenue and Organic Revenue Growth

The following table reconciles Organic Revenue and Organic Revenue Growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:

*(in thousands, except percentages)*

|  | For the Three Months Ended September 30, 2022 | 2021 | For the Nine Months Ended September 30, 2022 | 2021 |
| --- | ---: | ---: | ---: | ---: |
| Commissions and fees | $259,368 | $135,556 | $734,676 | $408,090 |
| Partnership commissions and fees(1) | (85,638) | (52,673) | (234,601) | (195,781) |
| Organic Revenue | $173,730 | $82,883 | $500,075 | $212,309 |
| Organic Revenue Growth(2) | $38,014 | $16,978 | $91,825 | $40,907 |
| Organic Revenue Growth %(2) | 28% | 26% | 22% | 24% |

(1) Includes the first twelve months of such commissions and fees generated from newly acquired Partners.

(2) Organic Revenue for the three and nine months ended September 30, 2021 used to calculate Organic Revenue Growth for the three and nine months ended September 30, 2022 was $135.7 million and $408.3 million, respectively, which is adjusted to reflect revenues from Partnerships that reached the twelve-month owned mark during the three and nine months ended September 30, 2022.

### Adjusted Net Income and Adjusted Diluted EPS

The following table reconciles Adjusted Net Income to net income (loss) attributable to BRP Group, Inc. and reconciles Adjusted Diluted EPS to diluted earnings (loss) per share, which we consider to be the most directly comparable GAAP financial measures:

*(in thousands, except per share data)*

|  | For the Three Months Ended September 30, 2022 | 2021(1) | For the Nine Months Ended September 30, 2022 | 2021(1) |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) attributable to BRP Group, Inc. | $(24,793) | $(13,212) | $6,718 | $(7,999) |
| Net income (loss) attributable to noncontrolling interests | (21,914) | (11,389) | 8,007 | (5,736) |
| Amortization expense | 23,180 | 12,596 | 59,912 | 33,875 |
| Transaction-related Partnership and integration expenses | 12,128 | 5,556 | 29,552 | 11,226 |
| Share-based compensation | 8,388 | 3,834 | 26,065 | 11,921 |
| (Gain) loss on interest rate caps, net of cash settlements | (3,602) | 334 | (24,871) | 1,159 |
| Change in fair value of contingent consideration | 21,695 | 11,341 | (10,809) | 23,163 |
| Amortization of deferred financing costs | 1,420 | 858 | 3,894 | 2,301 |
| Depreciation | 1,216 | 753 | 3,309 | 1,920 |
| Severance | 260 | 481 | 1,135 | 481 |
| Other(2) | 5,109 | 1,951 | 13,083 | 4,222 |
| Adjusted pre-tax income | 23,087 | 13,103 | 115,995 | 76,533 |
| Adjusted income taxes(3) | 2,286 | 1,297 | 11,484 | 7,577 |
| Adjusted Net Income | $20,801 | $11,806 | $104,511 | $68,956 |
| Weighted-average shares of Class A common stock outstanding - diluted | 57,282 | 46,446 | 59,895 | 45,132 |
| Dilutive effect of unvested restricted shares of Class A common stock | 3,675 | 1,818 | — | 1,737 |
| Exchange of Class B shares(4) | 55,151 | 52,148 | 55,743 | 50,521 |
| Adjusted dilutive weighted-average shares outstanding | 116,108 | 100,412 | 115,638 | 97,390 |
| Adjusted Diluted EPS | $0.18 | $0.12 | $0.90 | $0.71 |
| Diluted earnings (loss) per share | $(0.43) | $(0.28) | $0.11 | $(0.18) |
| Effect of exchange of Class B shares and net income (loss) attributable to noncontrolling interests per share | 0.03 | 0.03 | 0.02 | 0.04 |
| Other adjustments to earnings (loss) per share | 0.60 | 0.38 | 0.87 | 0.93 |
| Adjusted income taxes per share | (0.02) | (0.01) | (0.10) | (0.08) |
| Adjusted Diluted EPS | $0.18 | $0.12 | $0.90 | $0.71 |

(1) Calculation was adjusted in the fourth quarter of 2021 to include depreciation. Prior year amounts have been conformed to current year presentation.

(2) Other addbacks to Adjusted Net Income include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, remediation efforts, professional fees and litigation costs, and bonuses.

(3) Represents corporate income taxes at assumed effective tax rate of 9.9% applied to adjusted pre-tax income.

(4) Assumes the full exchange of Class B shares for Class A common stock pursuant to the Amended LLC Agreement.

### OPERATING GROUP RESULTS

### Commissions and Fees

In the Middle Market, MainStreet and Specialty Operating Groups, we generate commissions and fees from insurance placement under both agency bill and direct bill arrangements. In addition, we generate profit-sharing income in each of those segments based on either the underlying Book of Business or performance, such as loss ratios. In the Middle Market and Specialty Operating Groups, we generate fees from service fee and consulting arrangements. Service fee arrangements are in place with certain customers in lieu of commission arrangements.

In the Specialty Operating Group, we generate policy fee and installment fee revenue for acting in the capacity of an MGA and fulfilling certain services on behalf of Insurance Company Partners.

In the Medicare Operating Group, we generate commissions and fees in the form of direct bill insurance placement and marketing income. Marketing income is earned through co-branded marketing campaigns with our Insurance Company Partners.

The following table sets forth our commissions and fees by Operating Group and for Corporate and Other by amount and as a percentage of our commissions and fees:

*Commissions and Fees by Operating Group (in thousands, except percentages)*

| Operating Group | For the Three Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $130,216 | 50% | $80,087 | 60% | $50,129 | 63% | $433,151 | 59% | $266,751 | 65% | $166,400 | 62% |
| Specialty | 97,929 | 38% | 41,986 | 31% | 55,943 | 133% | 221,753 | 30% | 97,173 | 24% | 124,580 | 128% |
| MainStreet | 39,894 | 15% | 8,760 | 6% | 31,134 | 355% | 78,601 | 11% | 25,558 | 6% | 53,043 | 208% |
| Medicare | 7,890 | 3% | 5,665 | 4% | 2,225 | 39% | 28,166 | 4% | 20,269 | 5% | 7,897 | 39% |
| Corporate and Other | (16,561) | (6)% | (942) | (1)% | (15,619) | n/m | (26,995) | (4)% | (1,661) | —% | (25,334) | n/m |
|  | $259,368 |  | $135,556 |  | $123,812 |  | $734,676 |  | $408,090 |  | $326,586 |  |

n/m not meaningful

Commissions and fees for our Middle Market Operating Group increased $50.1 million for the third quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $36.5 million and organic growth of $13.6 million. Organic growth included $12.0 million related to base commissions and fees.

Commissions and fees for our Middle Market Operating Group increased $166.4 million for the first nine months of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $130.4 million and organic growth of $36.0 million. Organic growth included $30.7 million related to base commissions and fees and $5.6 million related to contingent revenue.

Commissions and fees for our Specialty Operating Group increased $55.9 million for the third quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $18.1 million, organic growth of $22.0 million and intercompany revenue of $15.8 million. Organic growth included $19.9 million attributable to our renter’s and homeowner’s insurance products, of which $10.4 million is related to the QBE Program Administrator Agreement, net of intercompany, which was entered into in connection with the Westwood Partnership, and $1.9 million related to contingent revenue.

Commissions and fees for our Specialty Operating Group increased $124.6 million for the first nine months of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $54.4 million, organic growth of $45.7 million and intercompany revenue of $24.5 million. Organic growth included $42.2 million attributable to our renter’s and homeowner’s insurance products, of which $17.9 million is related to the QBE Program Administrator Agreement, net of intercompany, which was entered into in connection with the Westwood Partnership, and $3.2 million related to contingent revenue.

Commissions and fees for our MainStreet Operating Group increased $31.1 million for the third quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $29.1 million and organic growth of $2.0 million, primarily related to base commissions and fees.

Commissions and fees for our MainStreet Operating Group increased $53.0 million for the first nine months of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $47.1 million and organic growth of $5.9 million, primarily related to base commissions and fees.

Commissions and fees for our Medicare Operating Group increased $2.2 million for the third quarter of 2022 as compared to the same period of 2021 as a result of the Partnership Contribution of $1.6 million and organic growth of $0.6 million.

Commissions and fees for our Medicare Operating Group increased $7.9 million for the first nine months of 2022 as compared to the same period of 2021 as a result of organic growth of $4.3 million and the Partnership Contribution of $3.6 million.

Revenue reported for Corporate and Other relates to the elimination of intercompany revenue. During the third quarter of 2022, the Middle Market Operating Group recorded intercompany commissions and fees from activity with the Specialty Operating Group of $0.4 million; the Specialty Operating Group recorded intercompany commissions and fees from activity with the MainStreet Operating Group and itself of $15.8 million; the MainStreet Operating Group recorded intercompany commissions and fees from activity with the Middle Market and Specialty Operating Groups of $0.2 million; and the Medicare Operating Group recorded intercompany commissions and fees from activity with itself of $0.2 million. These amounts were eliminated through Corporate and Other.

During the first nine months of 2022, the Middle Market Operating Group recorded intercompany commissions and fees from activity with the Specialty Operating Group of $1.1 million; the Specialty Operating Group recorded intercompany commissions and fees from activity with the MainStreet Operating Group and itself of $24.5 million; the MainStreet Operating Group recorded intercompany commissions and fees from activity with the Middle Market and Specialty Operating Groups of $0.4 million; and the Medicare Operating Group recorded intercompany commissions and fees from activity with itself of $1.0 million. These amounts were eliminated through Corporate and Other.

The substantial increase in intercompany commissions and fees for each of the quarter and year-to-date periods is related to the QBE Program Administrator Agreement, which was entered into in connection with the Westwood Partnership. We expect that revenue relating to this agreement will continue to grow as we serve as the MGA on more intersegment revenue such as homeowners’ insurance sold through the MainStreet Operating Group.

### Commissions, Employee Compensation and Benefits

The following table sets forth our commissions, employee compensation and benefits by Operating Group and for Corporate and Other by amount and as a percentage of our commissions, employee compensation and benefits:

*Commissions, Employee Compensation and Benefits by Operating Group (in thousands, except percentages)*

| Operating Group | For the Three Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $97,417 | 50% | $56,690 | 56% | $40,727 | 72% | $284,605 | 55% | $164,412 | 59% | $120,193 | 73% |
| Specialty | 73,293 | 37% | 30,739 | 31% | 42,554 | 138% | 160,830 | 31% | 71,118 | 26% | 89,712 | 126% |
| MainStreet | 23,039 | 12% | 5,547 | 6% | 17,492 | n/m | 47,747 | 9% | 16,573 | 6% | 31,174 | 188% |
| Medicare | 5,645 | 3% | 3,843 | 4% | 1,802 | 47% | 17,791 | 3% | 12,196 | 4% | 5,595 | 46% |
| Corporate and Other | (3,474) | (2)% | 3,262 | 3% | (6,736) | (206)% | 11,545 | 2% | 14,222 | 5% | (2,677) | (19)% |
|  | $195,920 |  | $100,081 |  | $95,839 |  | $522,518 |  | $278,521 |  | $243,997 |  |

n/m not meaningful

Commissions, employee compensation and benefits expenses increased across all Operating Groups for each of the quarter and year-to-date periods of 2022 as compared to the same periods of 2021. The Partnership Contribution accounted for $19.7 million, $9.5 million, $14.1 million and $1.2 million of the increase to commissions, employee compensation and benefits expenses in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively, for the quarter. The Partnership Contribution accounted for $72.7 million, $29.5 million, $22.6 million and $1.9 million of the increase to commissions, employee compensation and benefits expenses in the Middle Market, Specialty, MainStreet and Medicare Operating Groups, respectively, for the year-to-date period. Commissions, employee compensation and benefits expenses also increased across all Operating Groups as a result of continued investments in hiring for our growth services team to support our growth, which costs are primarily allocated among the Operating Groups, and continued investment in sales and service talent. In addition, there have been significant increases in the cost of human capital in the current year as a result of the increasingly competitive market and the inflationary environment, which has impacted employee compensation and benefits costs for both the quarter and year-to-date periods.

Commissions, employee compensation and benefits expenses for Corporate and Other decreased for both the quarter and year-to-date periods of 2022 as compared to the same period of 2021 as a result of the elimination of intercompany expense, offset in part by our continued investments in hiring to support our growth and additional share-based compensation expense. Commissions, employee compensation and benefits expenses for Corporate and Other includes elimination amounts of $16.6 million and $27.0 million for the quarter and year-to-date periods of 2022, respectively, as compared to $0.9 million and $1.7 million for the quarter and year-to-date periods of 2021, respectively.

The substantial increase in intercompany commissions, employee compensation and benefits expense for each of the quarter and year-to-date periods is related to the QBE Program Administrator Agreement. We expect that commissions expense relating to this agreement will continue to grow as we serve as the MGA on more intersegment revenue such as homeowners’ insurance sold through the MainStreet Operating Group.

### Other Operating Expenses

The following table sets forth our other operating expenses by Operating Group and for Corporate and Other by amount and as a percentage of our other operating expenses:

*Other Operating Expenses by Operating Group (in thousands, except percentages)*

| Operating Group | For the Three Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $20,130 | 43% | $13,749 | 49% | $6,381 | 46% | $52,703 | 42% | $31,579 | 49% | $21,124 | 67% |
| Specialty | 8,031 | 17% | 4,343 | 16% | 3,688 | 85% | 21,184 | 17% | 8,386 | 13% | 12,798 | 153% |
| MainStreet | 4,422 | 9% | 1,169 | 4% | 3,253 | 278% | 11,969 | 10% | 3,464 | 5% | 8,505 | 246% |
| Medicare | 1,778 | 4% | 1,134 | 4% | 644 | 57% | 4,497 | 4% | 3,621 | 6% | 876 | 24% |
| Corporate and Other | 12,851 | 27% | 7,573 | 27% | 5,278 | 70% | 34,071 | 27% | 17,330 | 27% | 16,741 | 97% |
|  | $47,212 |  | $27,968 |  | $19,244 |  | $124,424 |  | $64,380 |  | $60,044 |  |

Other operating expenses for our Middle Market Operating Group increased $6.4 million for the third quarter of 2022 as compared to the same period of 2021 driven by higher costs for dues and subscriptions of $2.6 million from our investment in technology to support our growth, travel and entertainment of $1.7 million relating to integration of our 2021 Partnerships, and rent expense of $0.4 million relating to expansion of our operating locations. Other operating expenses for our Specialty Operating Group increased $3.7 million for the third quarter of 2022 as compared to the same period of 2021 driven by higher costs for dues and subscriptions of $1.1 million from our investment in technology to support our growth, travel and entertainment of $0.9 million relating to integration of our 2021 Partnerships, bank charges of $0.3 million, and consulting fees and recruiting expense of $0.2 million each. Other operating expenses for our MainStreet Operating Group increased $3.3 million for the third quarter of 2022 as compared to the same period of 2021 driven by higher advertising and marketing of $1.6 million, rent expense of $0.6 million, dues and subscriptions of $0.4 million from our investment in technology to support our growth, travel and entertainment of $0.3 million and recruiting expense of $0.2 million. Other operating expenses for our Medicare Operating Group increased $0.6 million for the third quarter of 2022 as compared to the same period of 2021 driven by higher dues and subscriptions from our investment in technology to support our growth and advertising and marketing expenses of $0.2 million each.

Other operating expenses for our Middle Market Operating Group increased $21.1 million for the first nine months of 2022 as compared to the same period of 2021 driven by higher costs for dues and subscriptions of $6.3 million from our investment in technology to support our growth, travel and entertainment of $4.4 million relating to integration of our 2021 Partnerships, rent expense of $4.3 million relating to expansion of our operating locations, Colleague education and welfare of $1.8 million relating to investments in our Colleagues, advertising and marketing of $1.2 million, licenses and taxes of $1.1 million and insurance expense of $1.0 million. Other operating expenses for our Specialty Operating Group increased $12.8 million for the first nine months of 2022 as compared to the same period of 2021 driven by higher costs for dues and subscriptions of $2.2 million from our investment in technology to support our growth, travel and entertainment of $1.6 million relating to integration of our 2021 Partnerships, rent expense of $0.8 million, Colleague education and welfare relating to investments in our Colleagues, bank charges and consulting fees of $0.7 million each, advertising and marketing, licenses and taxes and professional fees of $0.6 million each. Other operating expenses for our MainStreet Operating Group increased $8.5 million for the first nine months of 2022 as compared to the same period of 2021 driven by higher advertising and marketing of $2.1 million, professional fees and rent expense relating to expansion of our operating locations of $1.7 million each, dues and subscriptions of $0.9 million from our investment in technology to support our growth, and recruiting expense of $0.7 million. Other operating expenses for our Medicare Operating Group increased $0.9 million for the first nine months of 2022 as compared to the same period of 2021 driven by higher costs for advertising and marketing of $0.5 million and dues and subscriptions of $0.3 million.

Other operating expenses in Corporate and Other increased $5.3 million for the third quarter of 2022 as compared to the same period of 2021 due to higher costs for travel and entertainment of $1.7 million relating to our leadership and Risk Advisor conference, professional fees of $1.2 million, Colleague education and welfare of $1.0 million relating to investments in our Colleagues, advertising and marketing and dues and subscriptions of $0.8 million each and repairs and maintenance of $0.6 million.

Other operating expenses in Corporate and Other increased $16.7 million for the first nine months of 2022 as compared to the same period of 2021 due to higher costs for Colleague education and welfare of $2.9 million relating to investments in our Colleagues, travel and entertainment of $2.8 million relating to our leadership and Risk Advisor conference, dues and subscriptions of $2.4 million, professional fees of $2.3 million, repairs and maintenance of $2.0 million, licenses and taxes of $1.6 million and recruiting expense of $1.1 million.

### Amortization Expense

The following table sets forth our amortization by Operating Group and for Corporate and Other by amount and as a percentage of our amortization:

*Amortization Expense by Operating Group (in thousands, except percentages)*

| Operating Group | For the Three Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $12,576 | 55% | $8,811 | 70% | $3,765 | 43% | $37,660 | 63% | $23,722 | 69% | $13,938 | 59% |
| Specialty | 4,275 | 18% | 2,936 | 23% | 1,339 | 46% | 12,689 | 21% | 7,663 | 23% | 5,026 | 66% |
| MainStreet | 5,869 | 25% | 395 | 3% | 5,474 | n/m | 8,275 | 14% | 1,221 | 4% | 7,054 | n/m |
| Medicare | 459 | 2% | 452 | 4% | 7 | 2% | 1,284 | 2% | 1,266 | 4% | 18 | 1% |
| Corporate and Other | 1 | —% | 2 | —% | (1) | —% | 4 | —% | 3 | —% | 1 | —% |
|  | $23,180 |  | $12,596 |  | $10,584 |  | $59,912 |  | $33,875 |  | $26,037 |  |

n/m not meaningful

Amortization expense increased for our Middle Market, Specialty and MainStreet Operating Groups for each of the quarter and year-to-date periods of 2022 as compared to the same periods of 2021 driven by amortization related to Partners acquired over the past twelve months. Amortization expense for the Medicare Operating Group was relatively flat.

### Change in Fair Value of Contingent Consideration

The following table sets forth our change in fair value of contingent consideration by Operating Group by amount and as a percentage of our change in fair value of contingent consideration:

*Change in Fair Value of Contingent Consideration by Operating Group (in thousands, except percentages)*

| Operating Group | For the Three Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  | For the Nine Months Ended September 30, 2022 Amount | Percent of Business | 2021 Amount | Percent of Business | Variance Amount% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Middle Market | $24,897 | 115% | $7,737 | 68% | $17,160 | 222% | $(6,115) | 57% | $16,783 | 72% | $(22,898) | (136)% |
| Specialty | (2,931) | (14)% | 3,002 | 26% | (5,933) | (198)% | (4,828) | 45% | 5,485 | 24% | (10,313) | (188)% |
| MainStreet | (487) | (2)% | 420 | 4% | (907) | (216)% | (49) | —% | 594 | 3% | (643) | (108)% |
| Medicare | 216 | 1% | 182 | 2% | 34 | 19% | 183 | (2)% | 301 | 1% | (118) | (39)% |
|  | $21,695 |  | $11,341 |  | $10,354 |  | $(10,809) |  | $23,163 |  | $(33,972) |  |

The change in fair value of contingent consideration for the third quarter of 2022 was impacted by changes in growth trends of certain partners, offset in part by high market volatility and rising interest rates, which resulted in an overall higher contingent earnout consideration value.

The change in fair value of contingent consideration for the year-to-date period of 2022 was impacted by high market volatility and rising interest rates, offset in part by changes in growth trends of certain partners, which resulted in an overall lower contingent earnout consideration value.

### LIQUIDITY AND CAPITAL RESOURCES

Our primary liquidity needs for the next twelve months will include cash to (i) provide capital to facilitate the organic growth of our business and to fund future Partnerships, (ii) pay operating expenses, including cash compensation to our employees and expenses related to being a public company, (iii) make payments under the Tax Receivable Agreement, (iv) pay interest and principal due on borrowings under the JPM Credit Agreement, (v) pay contingent earnout liabilities and (vi) pay taxes.

We have historically financed our operations and funded our debt service through the sale of our insurance products and services, and we have financed significant cash needs to fund growth through the acquisition of Partners through debt and equity financing.

At September 30, 2022, our cash and cash equivalents were $158.6 million and we had $73.0 million of available borrowing capacity on the Revolving Facility under the JPM Credit Agreement. We believe that our cash and cash equivalents, cash flow from operations and available borrowings will be sufficient to fund our working capital and meet our commitments for the next twelve months and beyond. In connection with our continuous exploration of Partnership opportunities, we will consider raising additional debt or equity financing if and as necessary to support our growth.

### JPM Credit Agreement

As of December 31, 2021, our JPM Credit Agreement provided for senior secured credit facilities in an aggregate principal amount of $1.325 billion, which consisted of (i) a term loan facility in the principal amount of $850.0 million maturing in 2027 (the “Term Loan B”) and (ii) a revolving credit facility with commitments in an aggregate principal amount of $475.0 million maturing in 2025 (the “Revolving Facility”).

On March 28, 2022, the Company entered into Amendment No. 5 to the JPM Credit Agreement, under which (i) the aggregate principal amount of the Revolving Facility was increased from $475.0 million to $600.0 million and (ii) the interest rate on the Revolving Facility changed to the SOFR, plus a credit spread adjustment of 10 bps, plus an amount between 200 bps and 300 bps based on the total net leverage ratio, (iii) the total net leverage ratio covenant increased to 7.0x consolidated EBITDA and (iv) the maturity of the Revolving Facility was extended to April 1, 2027. The other terms of the Revolving Facility and the terms of the Term Loan B remained unchanged.

The Term Loan B bears interest at LIBOR plus 350 bps, subject to a LIBOR floor of 50 bps. The applicable interest rate on the Term Loan B at September 30, 2022 was 6.26%. Borrowings under the Revolving Facility accrue interest at SOFR plus 210 bps to SOFR plus 310 bps based on total net leverage ratio. BRP will pay a letter of credit fee equal to the margin then in effect with respect to SOFR loans under the Revolving Facility multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee and any customary documentary and processing charges for any letter of credit issued under the JPM Credit Agreement. The outstanding borrowings on the Revolving Facility of $527.0 million had an applicable interest rate of 6.07% at September 30, 2022. The Revolving Facility is also subject to a commitment fee of 0.40% on the unused capacity at September 30, 2022.

The Revolving Facility and the Term Loan B are collateralized by a first priority lien on substantially all the assets of BRP, including a pledge of all equity securities of certain of its subsidiaries. The JPM Credit Agreement contains covenants that, among other things, restrict our ability to make certain restricted payments, incur additional debt, engage in certain asset sales, mergers, acquisitions or similar transactions, create liens on assets, engage in certain transactions with affiliates, change our business, make certain investments or restrict BRP’s ability to make dividends or other distributions to BRP Group. In addition, the JPM Credit Agreement contains financial covenants requiring us to maintain our Total First Lien Net Leverage Ratio (as defined in the JPM Credit Agreement) at or below 7.00 to 1.00.

### Contractual Obligations and Commitments

The following table represents our contractual obligations, aggregated by type, at September 30, 2022:

*(in thousands)*

|  | Payments Due by Period Total | Less than 1 year | 1-3 years | 3-5 years | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating leases(1) | $120,554 | $17,982 | $36,810 | $32,474 | $33,288 |
| Debt obligations payable(2) | 1,769,375 | 92,821 | 184,043 | 692,956 | 799,555 |
| Maximum future contingent payment obligation(3) | 980,505 | 150,802 | 819,703 | 10,000 | — |
| USF Grant | 5,260 | 520 | 1,388 | 1,720 | 1,632 |
| Total | $2,875,694 | $262,125 | $1,041,944 | $737,150 | $834,475 |

(1) Represents noncancelable operating leases for our facilities. Rent expense was $19.7 million and $12.5 million for the nine months ended September 30, 2022 and 2021, respectively.

(2) Represents scheduled debt obligations and estimated interest payments under the JPM Credit Agreement.

(3) Includes $229.6 million of current and non-current estimated contingent earnout liabilities at September 30, 2022.

Our contractual obligations and commitments are comprised of operating lease obligations, principal and interest payments on our borrowings under the JPM Credit Agreement, potential payments of contingent earnout liabilities and our commitment to the University of South Florida (“USF”).

Our operating lease obligations represent noncancelable agreements for our corporate headquarters and office space for our insurance brokerage business. Our operating lease agreements expire through December 2030. These obligations do not include leases with an initial term of 12 months or less, which are expensed as incurred. We may extend, terminate or otherwise modify or sub-lease facilities as needed to best suit the needs of our business. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised.

Borrowings under our JPM Credit Agreement include $840.2 million under the Term Loan B and $527.0 million on the Revolving Facility. Interest payable on outstanding borrowings on the Term Loan B and Revolving Facility in the table above was calculated based on applicable interest rates at September 30, 2022 of 6.26% and 6.07%, respectively, through their respective expiration dates of October 2027 and April 2027.

Substantially all of our Partnerships and certain acquisitions of select books of business that do not constitute a complete business enterprise include contractual earnout provisions. We record an estimation of the fair value of the contingent earnout obligations at the Partnership date as a component of the consideration paid. Our contingent earnout obligations are measured at fair value at each reporting period based on the present value of the expected future payments to be made to Partners in accordance with the provisions outlined in the respective purchase agreements. The recorded obligations are based on estimates of the Partners future performance using financial projections for the earnout period. The maximum future contingent payment obligation at September 30, 2022 was $980.5 million, of which $78.4 million must be settled in cash and the remaining $902.1 million can be settled in cash or stock at our option. The aggregate estimated contingent earnout liabilities included on our consolidated balance sheet at September 30, 2022 was $229.6 million, of which $24.4 million must be settled in cash and the remaining $205.2 million can be settled in cash or stock at our option.

We have a commitment to USF to donate a total of $5.3 million through October 2028. The gift will provide support for the School of Risk Management and Insurance in the USF Muma College of Business. It is currently anticipated that Lowry Baldwin, our Board Chair, will fund half of this commitment.

### Tax Receivable Agreement

We expect to obtain an increase in our share of our tax basis of the assets when BRP’s LLC Units are redeemed or exchanged for shares of BRP Group’s Class A common stock. This increase in tax basis may have the effect of reducing the future amounts paid to various tax authorities. The increase in tax basis may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.

We have a Tax Receivable Agreement that provides for the payment by us to the parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that we actually realize as a result of (i) any increase in tax basis in BRP Group’s assets and (ii) tax benefits related to imputed interest deemed arising as a result of payments made under the tax receivable agreement.

During the nine months ended September 30, 2022, we redeemed 1,734,568 LLC Units of BRP on a one-for-one basis for shares of Class A common stock and cancelled the corresponding shares of Class B common stock. We receive an increase in our share of the tax basis in the net assets of BRP due to the interests being redeemed. We have assessed the realizability of the net deferred tax assets and in that analysis have considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. We have recorded a full valuation allowance against the deferred tax assets at BRP Group as of September 30, 2022, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.

### SOURCES AND USES OF CASH

The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:

*(in thousands)*

|  | For the Nine Months Ended September 30, 2022 | 2021 | Variance |
| --- | ---: | ---: | ---: |
| Net cash provided by (used in) operating activities | $(16,653) | $27,041 | $(43,694) |
| Net cash used in investing activities | (407,466) | (223,581) | (183,885) |
| Net cash provided by financing activities | 446,999 | 475,955 | (28,956) |
| Net increase in cash and cash equivalents and restricted cash | 22,880 | 279,415 | (256,535) |
| Cash and cash equivalents and restricted cash at beginning of period | 227,737 | 142,022 | 85,715 |
| Cash and cash equivalents and restricted cash at end of period | $250,617 | $421,437 | $(170,820) |

42

### Operating Activities

The primary sources and uses of cash for operating activities are net income adjusted for non-cash items and changes in assets and liabilities. Net cash provided by operating activities decreased $43.7 million for the first nine months of 2022 as compared to the same period of 2021 driven by a decrease in cash relating to payments of contingent earnout consideration and related party notes payable. Payment of contingent earnout consideration in excess of the liability recognized at the acquisition date of $48.9 million is captured as an operating cash flow during 2022 and is reflective of Partnerships that have outperformed on our platform since the date of Partnership. Cash also decreased from a higher balance in premiums, commissions and fees receivable of $39.0 million resulting from revenue growth and the timing of revenue recognition under direct bill policies in employee benefits for which payment is received monthly through the duration of the year. These decreases were partially offset by an increase in cash from a higher balance in accounts payable, accrued expenses and other current liabilities of $41.5 million related, in part, to the aforementioned revenue growth and higher premiums receivable balance.

### Investing Activities

The primary sources and uses of cash for investing activities relate to cash consideration paid to fund Partnerships and other investments, as well as capital expenditures. Net cash used in investing activities increased $183.9 million for the first nine months of 2022 as compared to the same period of 2021 driven by an increase in cash consideration paid for Partnership activity of $170.9 million due to completing our largest Partnership to date during the second quarter of 2022. In addition, capital expenditures increased $12.2 million as a result of purchases to support our growth and software development projects for infrastructure to support our business, including key customer relationship management software.

### Financing Activities

The primary sources and uses of cash for financing activities relate to the issuance of our Class A common stock, borrowings from and repayment to our credit agreements, payment of debt issuance costs, payment of contingent earnout consideration, and other equity transactions. Net cash provided by financing activities decreased $29.0 million for the first nine months of 2022 as compared to the same period of 2021 driven by a decrease in proceeds of $268.3 million from an equity raise completed during 2021 and an increase in payments of contingent earnout consideration up to the amount of purchase price accrual of $46.1 million, offset in part by an increase in net borrowings on our credit facilities of $270.0 million.

### CRITICAL ACCOUNTING ESTIMATES

In preparing our financial statements in accordance with GAAP, we are required to make estimates and assumptions that affect the amounts of assets, liabilities, revenue, expenses, disclosure of contingent assets and liabilities and accompanying disclosures. We evaluate our estimates and assumptions on an ongoing basis. These estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances; although, actual results may differ from these estimates and assumptions. To the extent that there are differences between our estimates and actual results, our financial condition, results of operations and cash flows will be affected.

There have been no material changes in our critical accounting policies during the three months ended September 30, 2022 as compared to those disclosed in the Critical Accounting Estimates section under Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K filed with the SEC on March 1, 2022.

### RECENT ACCOUNTING PRONOUNCEMENTS

Please refer to Note 1 to our condensed consolidated financial statements included in Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.

## Market risk

As filed, 3,373 characters.

Market risk is the potential loss arising from adverse changes in market rates and prices, such as premium amounts, interest rates and equity prices. We are exposed to market risk through our investments and borrowings under the JPM Credit Agreement. We use derivative instruments to mitigate our risk related to the effect of rising interest rates on our cash flows. However, we do not use derivative instruments for trading or speculative purposes.

Our invested assets are held primarily as cash and cash equivalents and restricted cash. To a lesser extent, we may also utilize certificates of deposit, U.S. treasury securities and professionally managed short duration fixed income funds. These investments are subject to market risk. The fair values of our invested assets at September 30, 2022 and December 31, 2021 approximated their respective carrying values due to their short-term duration and therefore, such market risk is not considered to be material.

Insurance premium pricing has historically been cyclical, based on the underwriting capacity of the insurance industry and economic conditions. External events, such as terrorist attacks, man-made and natural disasters, can also have significant impacts on the insurance market. We use the terms ‘‘soft market’’ and ‘‘hard market’’ to describe the business cycles experienced by the industry. A soft market is an insurance market characterized by a period of declining premium rates, which can negatively affect commissions earned by insurance agents. A hard market is an insurance market characterized by a period of rising premium rates, which, absent other changes, can positively affect commissions earned by insurance agents.

We do not actively invest or trade in equity securities. In addition, we generally dispose of any significant equity securities held by Partners received in conjunction with an acquisition shortly after the acquisition date.

At September 30, 2022, we had $840.2 million and $527.0 million of borrowings outstanding under the Term Loan B and the Revolving Facility, respectively. These borrowings bear interest on a floating basis tied to either the prime rate or one of various other variable rates as defined in the JPM Credit Agreement. The variable rate currently in effect for the Term Loan B and the Revolving Facility is LIBOR and SOFR, respectively. These borrowings are subject to market risk. For additional information, see “JPM Credit Agreement” under Part II. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q.

We have entered into interest rate cap agreements to limit the potential impact of interest rate changes on cash flows. However, one of these agreements expired during March 2022 and three others were sold during May 2022, thereby increasing our overall exposure to rising interest rates. The interest rate cap agreement in place at September 30, 2022 mitigates the interest rate volatility on $300.0 million of debt to a maximum of 1.50% and the remaining $1.1 billion in debt remains subject to interest rate volatility. Taking the interest rate cap agreement into consideration, an increase of 100 basis points on the variable interest rates in effect at September 30, 2022 would increase our annual interest expense for the JPM Credit Agreement by $10.7 million.

## Controls and procedures

As filed, 3,638 characters.

### Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, because of the material weaknesses in our internal control over financial reporting described in our Annual Report on Form 10-K for the year ended December 31, 2021, our disclosure controls and procedures were not effective as of September 30, 2022.

Notwithstanding the material weaknesses in internal control over financial reporting, our management concluded that our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, when read with the notes thereto, present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with GAAP.

We completed nine Partnerships for an aggregate purchase price of $1.1 billion during the twelve months ended September 30, 2022. Guidance from the staff of the Securities and Exchange Commission provides that the staff will not take exception to companies that exclude acquisitions from their assessment of internal control over financial reporting during the first year of an acquisition, and our management has elected to exclude all nine Partnerships from our assessment as of September 30, 2022. The nine Partnerships represent approximately 9% of our consolidated total assets (the calculation excludes the goodwill and intangible assets of those acquired entities as the goodwill and intangible assets were subject to management’s assessment of internal control over financial reporting) and approximately 25% of total revenues as of and for the nine months ended September 30, 2022, respectively.

### Changes in Internal Control over Financial Reporting

Except with respect to our ongoing remediation efforts with respect to the aforementioned material weaknesses, there were no changes in our internal control over financial reporting that occurred during the quarter-ended September 30, 2022 that materially affected, or that are reasonably likely to materially affect our internal control over financial reporting.

## Risk factors

As filed, 136 characters.

See the risk factors outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.

Filed Nov 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001781755-22-000033. Last ingested by Listed: Nov 10, 2026, 03:23 ET. No prices; not investment advice.
